Effect of AIDET on Physician-Patient Communication

NCT ID: NCT01947400

Last Updated: 2015-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patient satisfaction is an important aspect of care and is gaining increasing importance as a measure of Healthcare quality. Tools for improving physician-patient communication are available but have not yet been tested in the Hospital setting. The purpose of this project is to determine if training in AIDET (Acknowledge, Introduce, Duration, Explanation, Thank) communication method improves physician-patient communication. Patient satisfaction data will be compared to historical controls using modified HCAHPS (Hospital Consumer Assessment of Health Plans Survey) as the primary outcome measure. In addition, a validation of delivery of AIDET communication will be accomplished through administration of questionnaires to patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a process of change study, which will compare HCAHPS patient satisfaction surveys before and after the Hospitalist receives AIDET physician-patient communication training. Once the Hospitalists agree to participate in the study, they will receive AIDET training by a Studor Group certified trainer. Both before and after the training intervention, Hospitalists' use of the AIDET method will be validated by having patients complete anonymous questionnaires during their hospital stay.

All HCAHPS surveys will be conducted by an external patient satisfaction survey vendor, and information will be de-identified both in terms of patient and specific Hospitalist. Validation questionnaires will be distributed by administrative staff, and will also be de-identified both in terms of patient and specific Hospitalist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physician Communication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospitalists

AIDET Training

Hospitalists

Intervention Type OTHER

AIDET Training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospitalists

AIDET Training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physicians: All physicians of the Hospital Medicine Service will be invited to participate

Exclusion Criteria

* Any invited physicians who refuse to consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nila Radhakrishnan, MD

Role: PRINCIPAL_INVESTIGATOR

University of Florida

Robert Leverence, MD

Role: STUDY_CHAIR

University of Florida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Florida

Gainesville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201200279

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.